Picture supply: Getty Pictures
The FTSE 100’s lengthy lagged the mighty S&P 500. Over the previous decade, the US index powered forward, fuelled by surging tech valuations, whereas the UK’s flagship index remained caught below the burden of sluggish banks and oil giants.
However 2025’s delivered a shock. To this point this yr, the Footsie’s returned over 7% — barely forward of the S&P 500’s roughly 6.5%. That’s a dramatic change in comparison with current years, and an indication that UK blue-chips are lastly holding their very own.
Dig a little bit deeper, and it’s clear what’s driving this. A handful of FTSE shares have smashed expectations, outperforming nearly each main US firm.
Mexico-focused silver miner Fresnillo is up greater than 130%, engineering heavyweight Babcock’s surged 116%, and Rolls-Royce continues its astonishing multi-year run, gaining one other 73% in 2025 alone.
Of all corporations on the S&P 500, solely Palantir’s within the prime three, edging barely forward of Rolls this yr with 84%. In fifth place is NRG Vitality, up 65% yr so far.
What’s driving the surge?
A lot of the expansion comes right down to particular tailwinds. Treasured metals are hovering amid world uncertainty, fuelling Fresnillo. Defence budgets are booming, propping up Babcock and Rolls. In the meantime, a recovering oil value and resilient world demand have helped shore up many FTSE stalwarts.
However a few of these strikes could also be getting forward of themselves. Share costs that rocket on hopes alone can simply grow to be ‘development traps’, the place valuation disconnects from long-term fundamentals. That’s why I choose to maintain a rational outlook when markets go a bit loopy.
Robust earnings, cheap valuations and stable stability sheets usually matter extra in the long term than short-term value jumps.
A extra cautious FTSE 100 choose
One inventory that’s performing extra ‘moderately’ proper now’s Beazley (LSE: BEZ). The specialist insurer has quietly delivered reasonable development this yr, up 8.8% — nothing flashy, however comfortably forward of the index’s historic averages.
Extra importantly, it’s supported by stable working traits. Earnings per share are rising at 9.9% yr on yr, with income up 7.8%. That’s feeding right into a wholesome internet margin of 18% and a powerful return on fairness (ROE) of 26.3%.
Valuation additionally appears to be like engaging. The shares commerce on a price-to-earnings (P/E) ratio of simply 6.67 and a price-to-book (P/B) a number of of 1.55, suggesting buyers aren’t paying over the chances for this high quality development.
It’s not a giant earnings play, however the dividend yield of two.8% is nicely lined by a payout ratio of simply 18.3%. Free money stream is reassuring at £1.26bn, comfortably outstripping its £614m of debt. Plus, the dividend has been raised for 3 years operating.
Dangers to look at
In fact, insurance coverage is usually a risky enterprise. Beazley faces publicity to large-catastrophe-linked losses, which might dent earnings in any given yr. It’s additionally weak to pricing cycles in speciality insurance coverage, which might swing from profitable to lean rapidly if competitors intensifies.
However total, I feel it’s the sort of stable British enterprise that’s price contemplating for sturdy reliability.
Whereas development shares fluctuate wildly, it’s these regular compounders — buying and selling on wise valuations — that usually ship the perfect returns over time. When constructing a diversified long-term portfolio, that’s precisely what buyers ought to be searching for.
